Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Purchases 184,567 Shares of Johnson & Johnson (NYSE:JNJ)

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its holdings in Johnson & Johnson (NYSE:JNJGet Rating) by 11.0% in the third quarter, Holdings Channel reports. The fund owned 1,859,667 shares of the company’s stock after purchasing an additional 184,567 shares during the quarter. Johnson & Johnson makes up 1.0% of Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings, making the stock its 18th biggest holding. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Johnson & Johnson were worth $303,795,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the stock. Morton Brown Family Wealth LLC lifted its position in Johnson & Johnson by 78.0% in the second quarter. Morton Brown Family Wealth LLC now owns 178 shares of the company’s stock worth $32,000 after buying an additional 78 shares during the last quarter. Goodman Advisory Group LLC purchased a new stake in shares of Johnson & Johnson in the second quarter valued at $39,000. Cardinal Capital Management Inc. lifted its holdings in shares of Johnson & Johnson by 333.3% in the 2nd quarter. Cardinal Capital Management Inc. now owns 260 shares of the company’s stock worth $46,000 after acquiring an additional 200 shares during the last quarter. First Bank & Trust boosted its stake in shares of Johnson & Johnson by 69.6% during the 2nd quarter. First Bank & Trust now owns 380 shares of the company’s stock worth $67,000 after purchasing an additional 156 shares during the period. Finally, Heritage Wealth Management LLC purchased a new stake in Johnson & Johnson in the 2nd quarter worth about $84,000. 67.94% of the stock is owned by institutional investors.

Insider Buying and Selling at Johnson & Johnson

In related news, CFO Joseph J. Wolk sold 14,781 shares of the business’s stock in a transaction that occurred on Tuesday, December 13th. The shares were sold at an average price of $179.60, for a total transaction of $2,654,667.60. Following the completion of the transaction, the chief financial officer now owns 35,812 shares in the company, valued at approximately $6,431,835.20. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Johnson & Johnson news, VP Peter Fasolo sold 29,275 shares of the company’s stock in a transaction that occurred on Monday, October 24th. The shares were sold at an average price of $171.36, for a total transaction of $5,016,564.00. Following the transaction, the vice president now owns 114,676 shares in the company, valued at approximately $19,650,879.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Joseph J. Wolk sold 14,781 shares of Johnson & Johnson stock in a transaction on Tuesday, December 13th. The stock was sold at an average price of $179.60, for a total transaction of $2,654,667.60. Following the sale, the chief financial officer now owns 35,812 shares of the company’s stock, valued at $6,431,835.20. The disclosure for this sale can be found here. Insiders have sold 277,886 shares of company stock worth $48,550,549 over the last quarter. Insiders own 0.35% of the company’s stock.

Johnson & Johnson Stock Performance

Shares of NYSE:JNJ opened at $168.74 on Friday. The firm has a 50 day moving average of $176.14 and a 200 day moving average of $171.25. The company has a quick ratio of 1.18, a current ratio of 1.43 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $441.17 billion, a price-to-earnings ratio of 23.50, a price-to-earnings-growth ratio of 3.28 and a beta of 0.56. Johnson & Johnson has a 52 week low of $155.72 and a 52 week high of $186.69.

Johnson & Johnson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 7th. Investors of record on Tuesday, February 21st will be paid a dividend of $1.13 per share. This represents a $4.52 dividend on an annualized basis and a dividend yield of 2.68%. The ex-dividend date of this dividend is Friday, February 17th. Johnson & Johnson’s dividend payout ratio (DPR) is currently 62.95%.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Sanford C. Bernstein dropped their target price on Johnson & Johnson from $194.00 to $190.00 in a research report on Wednesday, October 19th. SVB Leerink cut their price objective on Johnson & Johnson from $194.00 to $186.00 and set an “outperform” rating on the stock in a research report on Friday. Credit Suisse Group initiated coverage on Johnson & Johnson in a research report on Thursday, November 17th. They set a “neutral” rating and a $170.00 target price for the company. Bank of America reduced their price target on shares of Johnson & Johnson from $185.00 to $178.00 and set a “neutral” rating on the stock in a research note on Friday, October 14th. Finally, Raymond James dropped their target price on shares of Johnson & Johnson from $192.00 to $185.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 19th. Seven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $181.75.

Johnson & Johnson Profile

(Get Rating)

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets.

Read More

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJGet Rating).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.